No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IGMS IGM Biosciences
- 9.810
- -0.310-3.06%
Trading May 10 15:19 ET
579.02MMarket Cap-2330P/E (TTM)
10.640High9.580Low161.12KVolume10.160Open10.120Pre Close1.63MTurnover1.37%Turnover RatioLossP/E (Static)59.02MShares17.70052wk High3.59P/B115.81MFloat Cap3.81052wk Low--Dividend TTM11.81MShs Float133.000Historical High--Div YieldTTM10.47%Amplitude3.810Historical Low10.094Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns With EPS Projections Amidst Clinical ...
Express News | Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target
IGM Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 119.3% Wedbush → $20 Reiterates Outperform → Outperform 04/18/2024 31.58% HC Wainwright & Co. →
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
Express News | IGM Biosciences Inc : RBC Cuts Target Price to $20 From $21
IGM Biosciences Q1 EPS $(0.83), Inline, Sales $497.00K Miss $760.00K Estimate
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 37.59 percent increase over losses of $(1.33) per share from the same p
Comments
Insiders expressed positive sentiment towards the company by buying at prices higher than current rates, reflecting their belief in the stock. The report suggests more insider buying would encourage the company.
2
Based on comprehensive media reports, I compiled a list of some institutions with deposits in the bank for your reference. $SVB Financial(SIVB.US$
ROKU: 26% cash, $487 million in Silicon Valley Bank. $Roku Inc(ROKU.US$
BLOCKFI: According to a bankruptcy filing, BlockFi has $227 million in "unprotected" funds at Silicon Valley Bank, possibly in violation of U.S. bankruptcy law.
RBLX: Roblox says 5% of its $3 billion cash and securities balance is held by S...
ROKU: 26% cash, $487 million in Silicon Valley Bank. $Roku Inc(ROKU.US$
BLOCKFI: According to a bankruptcy filing, BlockFi has $227 million in "unprotected" funds at Silicon Valley Bank, possibly in violation of U.S. bankruptcy law.
RBLX: Roblox says 5% of its $3 billion cash and securities balance is held by S...
4
2
$IGM Biosciences(IGMS.US$ C'mon.. Just rise a little bit more...... =/
Gainers
• $MillerKnoll(MLKN.US$ +12.4%, $BioNTech(BNTX.US$ +7.4%, $Lululemon Athletica(LULU.US$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
• $MillerKnoll(MLKN.US$ +12.4%, $BioNTech(BNTX.US$ +7.4%, $Lululemon Athletica(LULU.US$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
18
8
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Pinchie McPincher : theye just announced updated formluation of fostrox
Pinchie McPincher : just announced updated formulation of fostrox , criticsal to support planned study with accelrated approval intent in 2nd lineHCC